load up load upBack up the truck everybody... ONCY is going to the moon... LOL...
So the company release 'great' data, and the price tanks almost 20%... Jeez good job it wasn't bad data.
So according to Matt Coffey, in 2019, Aware-1 data was all that was needed to get Roche to pull the trigger (presumably on a deal and not just blowing their own brains out).
Then we get Matt telling us that Aware-1 will be done in a few months...Then we get Bracelet-1, and setting up competition between would be partners/buyers...
So Pfizer has pulled out... and ONCY has already signalled that they may not have a CPI - language for, didn't work like we'd hoped... so if there is no value to the Check Point inhibitor company... who, just who is going to pay for the Phase III... and they need to hurry because that patent clock is ticking down...
For a product with such potential, these clowns have done their very best to keep it from succeeding... Even their sole partner Adlai Norttye no longer mentions Pela in the product pipeline...
Noteable may well now be espousing that Pela will be trialled with Car-T, crushed cookies and cream, and any other combo, but if they do not get approval BEFORE the patents run out... it is GAME over.
and I very much doubt big pharma is in a rush and giddy to do a deal... listen to Canadafan and Noteable, and you'll lose time and again... .only way to make money here, is to trade this tired old dog.